Loading clinical trials...

Two-Part Study to Evaluate the Safety and Efficacy of Image Guided Surgery Using Indocyanine Green for Intramolecular Imaging of Nervous System Tumors Compared to Standard of Care, (TumorGlow) | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 1NCT03262636

Two-Part Study to Evaluate the Safety and Efficacy of Image Guided Surgery Using Indocyanine Green for Intramolecular Imaging of Nervous System Tumors Compared to Standard of Care, (TumorGlow)

Primary malignant and non-malignant brain tumors account for an estimated 21.42 cases per 100,000 for a total count of 343,175 incident tumors based on worldwide population estimates \[1\]. These enti...

Lead sponsor: University of Pennsylvania•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITINGPhase 2

Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA

NCT02800486 · Glioblastoma, Anaplastic Astrocytoma, and more

RECRUITING

Glutamate Excitotoxicity and Its Role in Glioblastoma Biology

NCT05775458 · Brain Tumor, Primary

RECRUITINGPhase 1/2

Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM

NCT03213002 · Glioblastoma Multiforme (GBM), Glioblastoma, and more

RECRUITINGNA

FeelFit: High-intensity Interval Training to Improve Self-reported Physical Fitness in Brain Tumor Patients

NCT06282562 · Brain Tumor, Primary, Exercise

RECRUITING

SeOuL cOhort of Brain Tumor MONitoring Study (SOLOMON)

NCT05254197 · Brain Tumor, Primary, Meningioma, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 23, 2026Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment363

Start dateJun 2015

Last updatedJan 23, 2026

Condition

Brain Tumor, Primary Brain Tumor, Recurrent

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 23, 2026Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions